ImmunityBio, Inc. IBRX Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s property, plant and equipment at cost?
- ImmunityBio, Inc. (IBRX) reported property, plant and equipment at cost of $228.53M in Q1 2026.
- How has ImmunityBio, Inc.'s property, plant and equipment at cost changed year-over-year?
- ImmunityBio, Inc.'s property, plant and equipment at cost decreased by 4.1% year-over-year, from $238.21M to $228.53M.
- What is the long-term trend for ImmunityBio, Inc.'s property, plant and equipment at cost?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s property, plant and equipment at cost has grown at a 14.7% compound annual growth rate (CAGR), from $114.4M to $226.75M.